Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway
Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway
复制标题
DOI:
10.1038/sj.onc.1209328
复制
发表时间:
2006-05-18
期刊:
影响因子:
8
通讯作者:
Ohh, M.
中科院分区:
文献类型:
--
作者:
Chung, J.;Roberts, A. M.;Ohh, M.
The von Hippel-Lindau (VHL) tumour suppressor gene encodes a substrate-specifying component of an E3 ubiquitin ligase that targets hypoxia-inducible factor (HIF) alpha subunits for degradation under normoxia. The VHL protein is composed of an N-terminal HIF alpha-binding ss domain and a C-terminal alpha domain, which is necessary and sufficient for the formation of the E3 multiprotein enzyme. A large number of disease-causing mutations in either the alpha or ss domain renders HIF alpha stable irrespective of oxygen tension, leading to the upregulation of numerous HIF-target genes, such as GLUT1 and VEGF. Here, we show that VHL forms a self-associated complex in vivo, but not in vitro, and demonstrate that coexpression of two different VHL missense mutants - one in the a domain and the other in the ss domain - restores HIF-mediated gene expression profile. These findings indicate that VHL homotypic complexes can function in vivo in a complementary fashion to target HIF alpha for ubiquitinmediated proteolysis, and potentially explain why VHL-associated tumours witha missense mutation-carrying VHL allele is almost invariably accompanied by a second VHL allele harbouring a gross truncation or deletion.